SEOUL, South Korea--(BUSINESS WIRE)--The precision medicine and biotechnology company, Macrogen (CEO Kap-Seok Yang, www.macrogen.com) (KOSDAQ: 038290), announced on December 20 that its NGS clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback